Class information for:
Level 1: STATINS//ATORVASTATIN//HMG COA REDUCTASE INHIBITORS

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
2292 2292 42.5 90%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
171 3       MONASCUS//CITRININ//MONASCUS PURPUREUS 58457
419 2             STATINS//EZETIMIBE//SIMVASTATIN 16502
2292 1                   STATINS//ATORVASTATIN//HMG COA REDUCTASE INHIBITORS 2292

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 STATINS authKW 1063465 33% 10% 765
2 ATORVASTATIN authKW 300439 9% 11% 202
3 HMG COA REDUCTASE INHIBITORS authKW 220639 6% 13% 131
4 FLUVASTATIN authKW 194172 3% 19% 76
5 PLEIOTROPIC EFFECTS authKW 183820 3% 21% 65
6 SIMVASTATIN authKW 128191 6% 7% 142
7 PRAVASTATIN authKW 83432 3% 9% 69
8 ROSUVASTATIN authKW 65599 3% 9% 58
9 3 HYDROXY 3 METHYLGLUTARYL COENZYME A REDUCTASE INHIBITORS authKW 64002 1% 19% 25
10 CERIVASTATIN authKW 42904 1% 17% 19

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with term
in class
1 Cardiac & Cardiovascular System 34724 48% 0% 1105
2 Peripheral Vascular Diseases 13724 23% 0% 528
3 Pharmacology & Pharmacy 2588 21% 0% 491
4 Hematology 634 6% 0% 134
5 Medicine, Research & Experimental 342 6% 0% 131
6 Medicine, General & Internal 318 7% 0% 163
7 Respiratory System 167 3% 0% 65
8 Physiology 116 3% 0% 80
9 Anesthesiology 35 1% 0% 25
10 Endocrinology & Metabolism 18 2% 0% 56

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 VASC MED ATHEROSCLEROSIS UNIT 31817 1% 17% 14
2 CARDIOL 28398 25% 0% 581
3 EMI 99 12 26642 0% 100% 2
4 YONSEI SEVERANCE HOSP 26642 0% 100% 2
5 GIL HEART 20781 0% 20% 8
6 LIPID THROMBOSIS 17760 0% 67% 2
7 PATOL VASC NEFROL EXPT 17760 0% 67% 2
8 ACCID EMERGENCY DIRECTORATE 17123 0% 43% 3
9 A205 CLIN 13321 0% 100% 1
10 ACUTE CORONARY CARE 13321 0% 100% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 ATHEROSCLEROSIS 10282 4% 1% 91
2 AMERICAN JOURNAL OF CARDIOLOGY 9954 6% 1% 142
3 JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 5669 3% 1% 69
4 ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 5512 2% 1% 56
5 JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS 4428 1% 2% 14
6 INTERNATIONAL JOURNAL OF CARDIOLOGY 4381 3% 1% 63
7 CIRCULATION 3571 4% 0% 82
8 CIRCULATION JOURNAL 3491 2% 1% 35
9 CARDIOVASCULAR DRUGS AND THERAPY 2996 1% 1% 21
10 CURRENT ATHEROSCLEROSIS REPORTS 2878 1% 2% 12

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 STATINS 1063465 33% 10% 765 Search STATINS Search STATINS
2 ATORVASTATIN 300439 9% 11% 202 Search ATORVASTATIN Search ATORVASTATIN
3 HMG COA REDUCTASE INHIBITORS 220639 6% 13% 131 Search HMG+COA+REDUCTASE+INHIBITORS Search HMG+COA+REDUCTASE+INHIBITORS
4 FLUVASTATIN 194172 3% 19% 76 Search FLUVASTATIN Search FLUVASTATIN
5 PLEIOTROPIC EFFECTS 183820 3% 21% 65 Search PLEIOTROPIC+EFFECTS Search PLEIOTROPIC+EFFECTS
6 SIMVASTATIN 128191 6% 7% 142 Search SIMVASTATIN Search SIMVASTATIN
7 PRAVASTATIN 83432 3% 9% 69 Search PRAVASTATIN Search PRAVASTATIN
8 ROSUVASTATIN 65599 3% 9% 58 Search ROSUVASTATIN Search ROSUVASTATIN
9 3 HYDROXY 3 METHYLGLUTARYL COENZYME A REDUCTASE INHIBITORS 64002 1% 19% 25 Search 3+HYDROXY+3+METHYLGLUTARYL+COENZYME+A+REDUCTASE+INHIBITORS Search 3+HYDROXY+3+METHYLGLUTARYL+COENZYME+A+REDUCTASE+INHIBITORS
10 CERIVASTATIN 42904 1% 17% 19 Search CERIVASTATIN Search CERIVASTATIN

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref. in
cl.
Shr. of ref. in
cl.
Citations
1 OSTADAL, P , (2012) STATINS AS FIRST-LINE THERAPY FOR ACUTE CORONARY SYNDROME?.EXPERIMENTAL & CLINICAL CARDIOLOGY. VOL. 17. ISSUE 4. P. 227 -236 87 60% 2
2 KUHN, EW , LIAKOPOULOS, OJ , STANGE, S , DEPPE, AC , SLOTTOSCH, I , CHOI, YH , WAHLERS, T , (2014) PREOPERATIVE STATIN THERAPY IN CARDIAC SURGERY: A META-ANALYSIS OF 90 000 PATIENTS.EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. VOL. 45. ISSUE 1. P. 17-26 50 76% 27
3 DRAPALA, A , SIKORA, M , UFNAL, M , (2014) STATINS, THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND HYPERTENSION - A TALE OF ANOTHER BENEFICIAL EFFECT OF STATINS.JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. VOL. 15. ISSUE 3. P. 250 -258 71 55% 9
4 DE GENNARO, L , BRUNETTI, ND , CORREALE, M , BUQUICCHIO, F , CALDAROLA, P , DI BIASE, M , (2014) STATIN THERAPY IN HEART FAILURE: FOR GOOD, FOR BAD, OR INDIFFERENT?.CURRENT ATHEROSCLEROSIS REPORTS. VOL. 16. ISSUE 1. P. - 49 82% 3
5 UNDAS, A , CELINSKA-LOWENHOFF, M , KACZOR, M , MUSIAL, J , (2004) NEW NONLIPID EFFECTS OF STATINS AND THEIR CLINICAL RELEVANCE IN CARDIOVASCULAR DISEASE.THROMBOSIS AND HAEMOSTASIS. VOL. 91. ISSUE 6. P. 1065 -1077 77 62% 42
6 MASON, JC , (2003) STATINS AND THEIR ROLE IN VASCULAR PROTECTION.CLINICAL SCIENCE. VOL. 105. ISSUE 3. P. 251-266 92 50% 80
7 BONETTI, PO , LERMAN, LO , NAPOLI, C , LERMAN, A , (2003) STATIN EFFECTS BEYOND LIPID LOWERING-ARE THEY CLINICALLY RELEVANT?.EUROPEAN HEART JOURNAL. VOL. 24. ISSUE 3. P. 225-248 82 43% 276
8 LUDMAN, A , VENUGOPAL, V , YELLON, DM , HAUSENLOY, DJ , (2009) STATINS AND CARDIOPROTECTION - MORE THAN JUST LIPID LOWERING?.PHARMACOLOGY & THERAPEUTICS. VOL. 122. ISSUE 1. P. 30-43 60 56% 83
9 BARAKAT, AF , SAAD, M , ABUZAID, A , MENTIAS, A , MAHMOUD, A , ELGENDY, IY , (2016) PERIOPERATIVE STATIN THERAPY FOR PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING.ANNALS OF THORACIC SURGERY. VOL. 101. ISSUE 2. P. 818 -825 46 68% 1
10 BELTOWSKI, J , (2005) STATINS AND MODULATION OF OXIDATIVE STRESS.TOXICOLOGY MECHANISMS AND METHODS. VOL. 15. ISSUE 2. P. 61-92 123 35% 8

Classes with closest relation at Level 1



Rank Class id link
1 14156 STATINS//SIMVASTATIN//P DIS TB INTERNAL MED
2 18626 PITAVASTATIN//NK 104//CAS 147526 32 7
3 413 STATINS//LOW DENSITY LIPOPROTEIN CHOLESTEROL//ATORVASTATIN
4 15692 STATINS//GRP COGNIT DECLINE DEGENERAT VASC DISORDERS//GRP PHARMACOL CEREBRAL I EMIA
5 37173 BLOOD ELEMENTAL LEVELS//CHOLESTEROL RATIOS//LIPOPROTEIN CHOLESTEROL RATIO
6 8340 STATINS//LOVASTATIN//SIMVASTATIN
7 19663 SIMVASTATIN//STATINS//FLUVASTATIN GELATIN COMPLEX
8 12502 C REACTIVE PROTEIN//HIGH SENSITIVITY REACTIVE PROTEIN HSCRP//RESTENOSIS
9 7582 L ARGININE//HYPERCHOLESTEROLEMIA//REGENERATED ENDOTHELIUM
10 9257 PRAVASTATIN//HMG COA REDUCTASE INHIBITORS//MEVALONIC ACID

Go to start page